UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
27.5 USD
-0.48 (-1.72%)
27.5 USD
0 (0%)
UTI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 76 industry peers in the Diversified Consumer Services industry. While UTI has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, UTI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
Each year in the past 5 years UTI has been profitable.
UTI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 7.63%, UTI is doing good in the industry, outperforming 72.37% of the companies in the same industry.
The Return On Equity of UTI (19.21%) is better than 82.89% of its industry peers.
UTI's Return On Invested Capital of 10.46% is amongst the best of the industry. UTI outperforms 82.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UTI is below the industry average of 10.30%.
The last Return On Invested Capital (10.46%) for UTI is above the 3 year average (7.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROIC | 10.46% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
1.3 Margins
UTI has a better Profit Margin (7.54%) than 67.11% of its industry peers.
UTI's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.99%, UTI is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
UTI's Operating Margin has improved in the last couple of years.
UTI has a Gross Margin (49.68%) which is in line with its industry peers.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% |
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
2. Health
2.1 Basic Checks
UTI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UTI has more shares outstanding than it did 1 year ago.
UTI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UTI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.34 indicates that UTI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.34, UTI is doing good in the industry, outperforming 78.95% of the companies in the same industry.
The Debt to FCF ratio of UTI is 1.57, which is an excellent value as it means it would take UTI, only 1.57 years of fcf income to pay off all of its debts.
UTI's Debt to FCF ratio of 1.57 is amongst the best of the industry. UTI outperforms 84.21% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that UTI is not too dependend on debt financing.
UTI has a Debt to Equity ratio (0.26) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Altman-Z | 3.34 |
ROIC/WACC1.23
WACC8.51%
2.3 Liquidity
A Current Ratio of 1.07 indicates that UTI should not have too much problems paying its short term obligations.
UTI has a Current ratio (1.07) which is in line with its industry peers.
UTI has a Quick Ratio of 1.07. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI has a Quick ratio (1.07) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.05% over the past year.
UTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 65.96% yearly.
Looking at the last year, UTI shows a quite strong growth in Revenue. The Revenue has grown by 14.05% in the last year.
Measured over the past years, UTI shows a very strong growth in Revenue. The Revenue has been growing by 22.67% on average per year.
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
3.2 Future
Based on estimates for the next years, UTI will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.51% on average per year.
The Revenue is expected to grow by 8.99% on average over the next years. This is quite good.
EPS Next Y-31.68%
EPS Next 2Y-11.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.23%
Revenue Next 2Y8.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.12, which indicates a rather expensive current valuation of UTI.
UTI's Price/Earnings is on the same level as the industry average.
UTI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
Based on the Price/Forward Earnings ratio of 35.31, the valuation of UTI can be described as expensive.
UTI's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of UTI to the average of the S&P500 Index (23.92), we can say UTI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.12 | ||
| Fwd PE | 35.31 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than 63.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than 64.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.04 | ||
| EV/EBITDA | 11.79 |
4.3 Compensation for Growth
UTI has a very decent profitability rating, which may justify a higher PE ratio.
UTI's earnings are expected to decrease with -11.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-11.51%
EPS Next 3YN/A
5. Dividend
5.1 Amount
UTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
27.5
-0.48 (-1.72%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners97.52%
Inst Owner Change0%
Ins Owners2.78%
Ins Owner Change5.07%
Market Cap1.50B
Revenue(TTM)835.62M
Net Income(TTM)63.02M
Analysts81.82
Price Target38.18 (38.84%)
Short Float %4.93%
Short Ratio3.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.09%
Min EPS beat(2)28.91%
Max EPS beat(2)69.26%
EPS beat(4)4
Avg EPS beat(4)73.64%
Min EPS beat(4)28.91%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)75.72%
EPS beat(12)10
Avg EPS beat(12)77.26%
EPS beat(16)14
Avg EPS beat(16)214.91%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.15%
Revenue beat(4)4
Avg Revenue beat(4)2.24%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.25%
Revenue beat(12)12
Avg Revenue beat(12)3.17%
Revenue beat(16)15
Avg Revenue beat(16)3.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)-43.81%
EPS NY rev (1m)-2.53%
EPS NY rev (3m)-21.31%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.12 | ||
| Fwd PE | 35.31 | ||
| P/S | 1.79 | ||
| P/FCF | 27.04 | ||
| P/OCF | 15.38 | ||
| P/B | 4.56 | ||
| P/tB | 5.3 | ||
| EV/EBITDA | 11.79 |
EPS(TTM)1.14
EY4.15%
EPS(NY)0.78
Fwd EY2.83%
FCF(TTM)1.02
FCFY3.7%
OCF(TTM)1.79
OCFY6.5%
SpS15.35
BVpS6.03
TBVpS5.19
PEG (NY)N/A
PEG (5Y)0.37
Graham Number12.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROCE | 13.99% | ||
| ROIC | 10.46% | ||
| ROICexc | 14.6% | ||
| ROICexgc | 16.35% | ||
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% | ||
| FCFM | 6.62% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 127.37% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 14.13 | ||
| Cash Conversion | 83.6% | ||
| Profit Quality | 87.84% | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 3.34 |
F-Score6
WACC8.51%
ROIC/WACC1.23
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
EPS Next Y-31.68%
EPS Next 2Y-11.51%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
Revenue Next Year9.23%
Revenue Next 2Y8.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.41%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year46.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.14%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y13.31%
OCF growth 3Y28.35%
OCF growth 5Y54.57%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
What is the valuation status for UTI stock?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
Can you provide the financial health for UTI stock?
The financial health rating of UNIVERSAL TECHNICAL INSTITUT (UTI) is 6 / 10.
What is the earnings growth outlook for UNIVERSAL TECHNICAL INSTITUT?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -31.68% in the next year.